{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:21:29Z","timestamp":1793316089489,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["RO1 EY026533"],"award-info":[{"award-number":["RO1 EY026533"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["RO1 EY031684"],"award-info":[{"award-number":["RO1 EY031684"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jtos.2023.08.001","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T11:51:19Z","timestamp":1691063479000},"page":"3-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Molecular nature of ocular surface barrier function, diseases that affect it, and its relevance for ocular drug delivery"],"prefix":"10.1016","volume":"30","author":[{"given":"Satinder","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peri","family":"Sohnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Swamynathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar M.","family":"Espana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9158-1511","authenticated-orcid":false,"given":"Shivalingappa K.","family":"Swamynathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4390","key":"10.1016\/j.jtos.2023.08.001_bib1","first-page":"1","article-title":"The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture","volume":"48","author":"Gipson","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib2","series-title":"Corneal epithelial development and homeostasis","author":"Swamynathan","year":"2023"},{"key":"10.1016\/j.jtos.2023.08.001_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.preteyeres.2012.02.003","article-title":"Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease","volume":"31","author":"Barabino","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109007","article-title":"Immune regulation of the ocular surface","volume":"218","author":"Chen","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib5","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1167\/iovs.13-12547","article-title":"The corneal epithelial basement membrane: structure, function, and disease","volume":"54","author":"Torricelli","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10409239209082560","article-title":"Basement membrane proteins: structure, assembly, and cellular interactions","volume":"27","author":"Paulsson","year":"1992","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.jtos.2023.08.001_bib7","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1167\/iovs.10-6134","article-title":"Regulation of corneal epithelial barrier function by kruppel-like transcription factor 4","volume":"52","author":"Swamynathan","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1128\/MCB.00846-06","article-title":"Conditional deletion of the mouse Klf4 gene results in corneal epithelial fragility, stromal edema, and loss of conjunctival goblet cells","volume":"27","author":"Swamynathan","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jtos.2023.08.001_bib9","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1167\/iovs.15-16463","article-title":"Spatiotemporally regulated ablation of Klf4 in adult mouse corneal epithelial cells results in altered epithelial cell identity and disrupted homeostasis","volume":"56","author":"Delp","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib10","doi-asserted-by":"crossref","first-page":"34304","DOI":"10.1074\/jbc.M113.504399","article-title":"The Ets transcription factor EHF as a regulator of cornea epithelial cell identity","volume":"288","author":"Stephens","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2023.08.001_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1167\/iovs.08-3327","article-title":"Essential role for Pbx1 in corneal morphogenesis","volume":"51","author":"Murphy","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib12","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1167\/iovs.10-6726","article-title":"Overexpression of Pax6 in mouse cornea directly alters corneal epithelial cells: changes in immune function, vascularization, and differentiation","volume":"52","author":"Davis","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib13","first-page":"1270","article-title":"Conjunctiva-associated lymphoid tissue in the human eye","volume":"41","author":"Knop","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000219678","article-title":"Conjunctiva-associated lymphoid tissue - current knowledge, animal models and experimental prospects","volume":"42","author":"Steven","year":"2009","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1469-7580.2005.00394.x","article-title":"The role of eye-associated lymphoid tissue in corneal immune protection","volume":"206","author":"Knop","year":"2005","journal-title":"J Anat"},{"key":"10.1016\/j.jtos.2023.08.001_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.preteyeres.2012.06.002","article-title":"Tear analysis in ocular surface diseases","volume":"31","author":"Zhou","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exer.2013.07.014","article-title":"Antimicrobial compounds in tears","volume":"117","author":"McDermott","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtos.2017.05.005","article-title":"TFOS DEWS II introduction","volume":"15","author":"Nelson","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2023.08.001_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000131066","article-title":"The normal tear film","volume":"41","author":"Tiffany","year":"2008","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.jtos.2023.08.001_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-4615-5359-5_40","article-title":"The meibomian glands and tear film lipids. Structure, function, and control","volume":"438","author":"Bron","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtos.2023.08.001_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exer.2013.07.027","article-title":"Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins","volume":"117","author":"Hodges","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.exer.2011.03.002","article-title":"Comparative proteomics of human male and female tears by two-dimensional electrophoresis","volume":"92","author":"Ananthi","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib23","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jproteome.5b00179","article-title":"Human basal tear peptidome characterization by CID, HCD, and ETD followed by in silico and in vitro analyses for antimicrobial peptide identification","author":"Azkargorta","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II tear film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2023.08.001_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1542-0124(12)70213-6","article-title":"Structure and biological roles of mucin-type O-glycans at the ocular surface","volume":"8","author":"Guzman-Aranguez","year":"2010","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2023.08.001_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000315016","article-title":"Antimicrobial peptides as a major part of the innate immune defense at the ocular surface","volume":"45","author":"Garreis","year":"2010","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.jtos.2023.08.001_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.729260","article-title":"The epithelial cell glycocalyx in ocular surface infection","volume":"12","author":"Argueso","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2023.08.001_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ACI.0b013e32830e6b04","article-title":"Functions of ocular surface mucins in health and disease","volume":"8","author":"Mantelli","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jtos.2023.08.001_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/ACI.0b013e3283645899","article-title":"The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases","volume":"13","author":"Mantelli","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jtos.2023.08.001_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(03)31001-0","article-title":"Role of mucins in the function of the corneal and conjunctival epithelia","volume":"231","author":"Gipson","year":"2003","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.jtos.2023.08.001_bib31","doi-asserted-by":"crossref","first-page":"23037","DOI":"10.1074\/jbc.M109.033332","article-title":"Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier","volume":"284","author":"Argueso","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2023.08.001_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.cellbio.23.090506.123357","article-title":"Mechanisms regulating epithelial stratification","volume":"23","author":"Koster","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.jtos.2023.08.001_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nature03922","article-title":"Asymmetric cell divisions promote stratification and differentiation of mammalian skin","volume":"437","author":"Lechler","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jtos.2023.08.001_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/103947","article-title":"Ocular surface development and gene expression","volume":"2013","author":"Swamynathan","year":"2013","journal-title":"Journal of ophthalmology"},{"key":"10.1016\/j.jtos.2023.08.001_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jtos.2023.04.002","article-title":"Transglutaminase-2 is critical for corneal epithelial barrier function via positive regulation of Claudin-1","volume":"28","author":"Hou","year":"2023","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2023.08.001_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4161\/cam.21831","article-title":"Laminins in basement membrane assembly","volume":"7","author":"Hohenester","year":"2013","journal-title":"Cell Adhes Migrat"},{"key":"10.1016\/j.jtos.2023.08.001_bib37","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrm.2016.80","article-title":"Tight junctions: from simple barriers to multifunctional molecular gates","volume":"17","author":"Zihni","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jtos.2023.08.001_bib38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0014-4835(03)00054-X","article-title":"Tight junction-related protein expression and distribution in human corneal epithelium","volume":"76","author":"Ban","year":"2003","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib39","first-page":"4093","article-title":"Corneal epithelial tight junctions and their response to lipopolysaccharide challenge","volume":"41","author":"Yi","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib40","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1167\/iovs.08-3046","article-title":"Tight junction transmembrane protein claudin subtype expression and distribution in human corneal and conjunctival epithelium","volume":"50","author":"Yoshida","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib41","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1167\/iovs.10-6125","article-title":"Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal","volume":"52","author":"Alarcon","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib42","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/IAI.02329-14","article-title":"The importance of the Pseudomonas aeruginosa type III secretion system in epithelium traversal depends upon conditions of host susceptibility","volume":"83","author":"Sullivan","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.jtos.2023.08.001_bib43","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1128\/iai.65.7.2861-2867.1997","article-title":"Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity","volume":"65","author":"Fleiszig","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.jtos.2023.08.001_bib44","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1128\/IAI.66.7.3443-3446.1998","article-title":"Susceptibility of epithelial cells to Pseudomonas aeruginosa invasion and cytotoxicity is upregulated by hepatocyte growth factor","volume":"66","author":"Fleiszig","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.jtos.2023.08.001_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024008","article-title":"3D quantitative imaging of unprocessed live tissue reveals epithelial defense against bacterial adhesion and subsequent traversal requires MyD88","volume":"6","author":"Tam","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2023.08.001_bib46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrm2927","article-title":"Adherens junctions: from molecules to morphogenesis","volume":"11","author":"Harris","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jtos.2023.08.001_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/B978-0-12-394311-8.00005-4","article-title":"Structure, function, and regulation of desmosomes","volume":"116","author":"Kowalczyk","year":"2013","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jtos.2023.08.001_bib49","doi-asserted-by":"crossref","first-page":"R1026","DOI":"10.1016\/j.cub.2013.10.067","article-title":"Gap junctions","volume":"23","author":"Shimizu","year":"2013","journal-title":"Curr Biol"},{"key":"10.1016\/j.jtos.2023.08.001_bib50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/sj.eye.6702972","article-title":"Reduced expression of the gap junction protein Connexin 43 in keratoconus","volume":"22","author":"Gatzioufas","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2023.08.001_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108002","article-title":"Corneal epithelial basement membrane: structure, function and regeneration","volume":"194","author":"Wilson","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib52","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/IAI.00111-09","article-title":"Role of the corneal epithelial basement membrane in ocular defense against Pseudomonas aeruginosa","volume":"77","author":"Alarcon","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.jtos.2023.08.001_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108033","article-title":"Bowman's layer in the cornea- structure and function and regeneration","volume":"195","author":"Wilson","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/biom13050771","article-title":"The cornea: No difference in the wound healing response to injury related to whether, or not, there's a bowman's layer","volume":"13","author":"Wilson","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jtos.2023.08.001_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1755-3768.1989.tb07099.x","article-title":"The role of the limbus in ocular surface maintenance and repair","volume":"192","author":"Thoft","year":"1989","journal-title":"Acta Ophthalmol Suppl"},{"key":"10.1016\/j.jtos.2023.08.001_bib56","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1167\/iovs.10-7068","article-title":"Mouse conjunctival forniceal gene expression during postnatal development and its regulation by Kruppel-like factor 4","volume":"52","author":"Gupta","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044771","article-title":"Critical role of Klf5 in regulating gene expression during post-eyelid opening maturation of mouse corneas","volume":"7","author":"Kenchegowda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2023.08.001_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ydbio.2011.05.005","article-title":"Conditional disruption of mouse Klf5 results in defective eyelids with malformed meibomian glands, abnormal cornea and loss of conjunctival goblet cells","volume":"356","author":"Kenchegowda","year":"2011","journal-title":"Dev Biol"},{"key":"10.1016\/j.jtos.2023.08.001_bib59","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1167\/iovs.12-10759","article-title":"Klf4 regulates the expression of Slurp1, which functions as an immunomodulatory peptide in the mouse cornea","volume":"53","author":"Swamynathan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1479-7364-4-4-263","article-title":"Kruppel-like factors: three fingers in control","volume":"4","author":"Swamynathan","year":"2010","journal-title":"Hum Genom"},{"key":"10.1016\/j.jtos.2023.08.001_bib61","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1167\/iovs.08-1811","article-title":"Identification of candidate Klf4 target genes reveals the molecular basis of the diverse regulatory roles of Klf4 in the mouse cornea","volume":"49","author":"Swamynathan","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib62","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1167\/iovs.09-3561","article-title":"Stromal edema in klf4 conditional null mouse cornea is associated with altered collagen fibril organization and reduced proteoglycans","volume":"50","author":"Young","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib63","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1167\/iovs.17-21826","article-title":"KLF4 plays an essential role in corneal epithelial homeostasis by promoting epithelial cell fate and suppressing epithelial-mesenchymal transition","volume":"58","author":"Tiwari","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib64","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1167\/iovs.18-26423","article-title":"KLF4 regulates corneal epithelial cell cycle progression by suppressing canonical TGF-beta signaling and upregulating CDK inhibitors P16 and P27","volume":"60","author":"Tiwari","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/iovs.61.5.15","article-title":"KLF4 coordinates corneal epithelial apical-basal polarity and plane of cell division and is downregulated in ocular surface squamous neoplasia","volume":"61","author":"Tiwari","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib66","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1167\/iovs.17-22498","article-title":"Spatiotemporally controlled ablation of Klf5 results in dysregulated epithelial homeostasis in adult mouse corneas","volume":"58","author":"Loughner","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2019.07.123","article-title":"The secreted Ly-6\/uPAR related protein-1 (SLURP1) stabilizes epithelial cell junctions and suppresses TNF-alpha-induced cytokine production","author":"Campbell","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtos.2023.08.001_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2021.12.006","article-title":"Secreted Ly-6\/uPAR-related protein-1 (SLURP1) is a pro-differentiation factor that stalls G1-S transition during corneal epithelial cell cycle progression","volume":"24","author":"Swamynathan","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2023.08.001_bib69","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.1167\/iovs.15-18206","article-title":"Corneal expression of SLURP-1 by age, sex, genetic strain, and ocular surface health","volume":"56","author":"Swamynathan","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib70","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.exer.2017.08.007","article-title":"Inhibition of HUVEC tube formation via suppression of NFkappaB suggests an anti-angiogenic role for SLURP1 in the transparent cornea","volume":"164","author":"Swamynathan","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib71","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1167\/iovs.14-15107","article-title":"SLURP-1 modulates corneal homeostasis by serving as a soluble scavenger of urokinase-type plasminogen activator","volume":"55","author":"Swamynathan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib72","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1038\/s41598-019-42437-x","article-title":"The secreted Ly6\/uPAR-related protein-1 suppresses neutrophil binding, chemotaxis, and transmigration through human umbilical vein endothelial cells","volume":"9","author":"Swamynathan","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2023.08.001_bib73","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0014-4835(03)00050-2","article-title":"Corneal nerves: structure, contents and function","volume":"76","author":"Muller","year":"2003","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/aos.13844","article-title":"Role of corneal nerves in ocular surface homeostasis and disease","volume":"97","author":"Labetoulle","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2023.08.001_bib75","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/eye.2014.263","article-title":"Neuropathic ocular pain: an important yet underevaluated feature of dry eye","volume":"29","author":"Galor","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2023.08.001_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40123-020-00263-9","article-title":"Ocular surface pain: a narrative review","volume":"9","author":"Mehra","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2023.08.001_bib77","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","article-title":"Ocular benzalkonium chloride exposure: problems and solutions","volume":"36","author":"Goldstein","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2023.08.001_bib79","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/all.15174","article-title":"Epithelial barrier dysfunction in ocular allergy","volume":"77","author":"Singh","year":"2022","journal-title":"Allergy (Cph)"},{"key":"10.1016\/j.jtos.2023.08.001_bib80","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/OPTH.S157430","article-title":"Recurrent corneal erosion: a comprehensive review","volume":"13","author":"Miller","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2023.08.001_bib81","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: what we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2023.08.001_bib82","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jtos.2022.10.001","article-title":"Imbalanced IL-37\/TNF-alpha\/CTSS signaling disrupts corneal epithelial barrier in a dry eye model in vitro","volume":"26","author":"Zhang","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2023.08.001_bib83","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1167\/iovs.07-0419","article-title":"Delayed disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-alpha in a manner dependent on NF-kappaB","volume":"49","author":"Kimura","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib84","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1167\/iovs.08-2606","article-title":"Interleukin-1 beta-induced disruption of barrier function in cultured human corneal epithelial cells","volume":"50","author":"Kimura","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108895","article-title":"Cathepsin S is a novel target for age-related dry eye","volume":"214","author":"Yu","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib86","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41385-020-0288-4","article-title":"IL-33\/ST2\/IL-9\/IL-9R signaling disrupts ocular surface barrier in allergic inflammation","volume":"13","author":"Hu","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jtos.2023.08.001_bib87","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41577-021-00538-7","article-title":"Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?","volume":"21","author":"Akdis","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtos.2023.08.001_bib88","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/mi.2013.61","article-title":"CD8(+) cells regulate the T helper-17 response in an experimental murine model of Sjogren syndrome","volume":"7","author":"Zhang","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jtos.2023.08.001_bib89","article-title":"Sjogren-Like lacrimal keratoconjunctivitis in germ-free mice","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.852918","article-title":"Gut microbiota from sjogren syndrome patients causes decreased T regulatory cells in the lymphoid organs and desiccation-induced corneal barrier disruption in mice","volume":"9","author":"Schaefer","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.jtos.2023.08.001_bib91","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.exer.2009.11.012","article-title":"Protection of human corneal epithelial cells from hypoxia-induced disruption of barrier function by hepatocyte growth factor","volume":"90","author":"Kimura","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib92","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.exer.2011.02.013","article-title":"Protective effect of dexamethasone against hypoxia-induced disruption of barrier function in human corneal epithelial cells","volume":"92","author":"Kimura","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib93","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jtos.2019.06.007","article-title":"The impact of hyperglycemia on the corneal epithelium: molecular mechanisms and insight","volume":"17","author":"Zhu","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2023.08.001_bib94","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41401-019-0223-y","article-title":"Diabetes inhibits corneal epithelial cell migration and tight junction formation in mice and human via increasing ROS and impairing Akt signaling","volume":"40","author":"Jiang","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jtos.2023.08.001_bib95","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.61.11.3","article-title":"Effect of high glucose on ocular surface epithelial cell barrier and tight junction proteins","volume":"61","author":"Alfuraih","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib96","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9440(10)64015-1","article-title":"Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations","volume":"158","author":"Saghizadeh","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2023.08.001_bib97","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1076\/0271-3683(200008)2121-VFT608","article-title":"Matrix metalloproteinase activity is enhanced during corneal wound repair in high glucose condition","volume":"21","author":"Takahashi","year":"2000","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib98","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/1535370220983243","article-title":"Nuclear translocation of beta-catenin induced by E-cadherin endocytosis causes recurrent erosion of diabetic cornea","volume":"246","author":"Ma","year":"2021","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.jtos.2023.08.001_bib99","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12886-020-01408-x","article-title":"Effect of epidermal growth factor ointment on persistent epithelial defects of the cornea","volume":"20","author":"Moon","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jtos.2023.08.001_bib100","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.febslet.2009.05.010","article-title":"Up-regulation of ZO-1 expression and barrier function in cultured human corneal epithelial cells by substance P","volume":"583","author":"Ko","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jtos.2023.08.001_bib101","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1167\/iovs.03-0189","article-title":"Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy","volume":"44","author":"Nagano","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib102","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1167\/iovs.02-0868","article-title":"Restoration of corneal epithelial barrier function and wound healing by substance P and IGF-1 in rats with capsaicin-induced neurotrophic keratopathy","volume":"44","author":"Nakamura","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib103","first-page":"96","article-title":"Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model","volume":"42","author":"Fujihara","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib104","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.ophtha.2012.04.010","article-title":"Diquafosol Ophthalmic Solution Phase 2 Study G. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial","volume":"119","author":"Matsumoto","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2023.08.001_bib105","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1007\/s12325-022-02194-2","article-title":"Efficacy and safety of the long-acting diquafosol ophthalmic solution DE-089C in patients with dry eye: a randomized, double-masked, placebo-controlled phase 3 study","volume":"39","author":"Hori","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.jtos.2023.08.001_bib106","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2147\/OPTH.S40798","article-title":"Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal","volume":"8","author":"Kashima","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2023.08.001_bib107","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1167\/iovs.12-11294","article-title":"Protection of human corneal epithelial cells from TNF-alpha-induced disruption of barrier function by rebamipide","volume":"54","author":"Kimura","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib108","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/bjophthalmol-2012-302868","article-title":"Rebamipide increases barrier function and attenuates TNFalpha-induced barrier disruption and cytokine expression in human corneal epithelial cells","volume":"97","author":"Tanaka","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2023.08.001_bib109","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/bjophthalmol-2014-305425","article-title":"Inhibition by rebamipide of cytokine-induced or lipopolysaccharide-induced chemokine synthesis in human corneal fibroblasts","volume":"98","author":"Fukuda","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2023.08.001_bib110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/jop.2020.0005","article-title":"Calcineurin inhibitor voclosporin preserves corneal barrier and conjunctival goblet cells in experimental dry eye","volume":"36","author":"Alam","year":"2020","journal-title":"J Ocul Pharmacol Therapeut : the official journal of the Association for Ocular Pharmacology and Therapeutics"},{"key":"10.1016\/j.jtos.2023.08.001_bib111","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1167\/iovs.17-22852","article-title":"Topical application of mizoribine suppresses CD4+ T-cell-mediated pathogenesis in murine dry eye","volume":"58","author":"Zhang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15682-1","article-title":"The Semaphorin 3A inhibitor SM-345431 preserves corneal nerve and epithelial integrity in a murine dry eye model","volume":"7","author":"Yamazaki","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2023.08.001_bib113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","article-title":"Corneal and conjunctival drug permeability: systematic comparison and pharmacokinetic impact in the eye","volume":"119","author":"Ramsay","year":"2018","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib114","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"Hamalainen","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2012.05.007","article-title":"Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes","volume":"47","author":"Loch","year":"2012","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib116","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s42003-023-04801-6","article-title":"Extending the use of biologics to mucous membranes by attachment of a binding domain","volume":"6","author":"Shanks","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jtos.2023.08.001_bib117","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2023.08.001_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2231-4040.197330","article-title":"Microneedles-mediated drug and vaccine delivery","volume":"8","author":"Nagaich","year":"2017","journal-title":"\"J Adv Pharm Technol Research\"\" (JAPTR)\""},{"key":"10.1016\/j.jtos.2023.08.001_bib119","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3762\/bjnano.13.98","article-title":"Microneedle-based ocular drug delivery systems - recent advances and challenges","volume":"13","author":"Gadzinski","year":"2022","journal-title":"Beilstein J Nanotechnol"},{"key":"10.1016\/j.jtos.2023.08.001_bib120","article-title":"Fabrication of a Ti porous microneedle array by metal injection molding for transdermal drug delivery","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2023.08.001_bib121","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.xphs.2022.01.033","article-title":"Intradermal administration of influenza vaccine with trehalose and pullulan-based dissolving microneedle arrays","volume":"111","author":"Tian","year":"2022","journal-title":"J Pharmacol Sci (Tokyo, Jpn)"},{"key":"10.1016\/j.jtos.2023.08.001_bib122","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.biomaterials.2011.01.014","article-title":"Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose","volume":"32","author":"Lee","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtos.2023.08.001_bib123","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11095-018-2369-6","article-title":"Delivery of methotrexate and characterization of skin treated by fabricated PLGA microneedles and fractional ablative laser","volume":"35","author":"Nguyen","year":"2018","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.jtos.2023.08.001_bib124","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s13346-021-01006-4","article-title":"Preparation and characterization of 3D printed PLA microneedle arrays for prolonged transdermal drug delivery of estradiol valerate","volume":"12","author":"Khosraviboroujeni","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2018.03.001","article-title":"Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle","volume":"277","author":"Jung","year":"2018","journal-title":"J Contr Release"},{"key":"10.1016\/j.jtos.2023.08.001_bib126","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1038\/s41467-018-06981-w","article-title":"Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery","volume":"9","author":"Than","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtos.2023.08.001_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202104657","article-title":"A rapid corneal healing microneedle for efficient ocular drug delivery","volume":"18","author":"Shi","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jtos.2023.08.001_bib128","first-page":"15","article-title":"Recent progress in chitosan-based nanomedicine for its ocular application in glaucoma","author":"Albarqi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2023.08.001_bib129","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2184312","article-title":"Physicochemical properties and micro-interaction between micro-nanoparticles and anterior corneal multilayer biological interface film for improving drug delivery efficacy: the transformation of tear film turnover mode","volume":"30","author":"Li","year":"2023","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jtos.2023.08.001_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060570","article-title":"Recent advances in the design of topical ophthalmic delivery systems in the treatment of ocular surface inflammation and their biopharmaceutical evaluation","volume":"12","author":"Mazet","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2023.08.001_bib131","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.12.018","article-title":"Polymeric nanoparticulate system: a potential approach for ocular drug delivery","volume":"136","author":"Nagarwal","year":"2009","journal-title":"J Contr Release"},{"key":"10.1016\/j.jtos.2023.08.001_bib132","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2219419","article-title":"Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases","volume":"30","author":"Zhao","year":"2023","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jtos.2023.08.001_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114817","article-title":"Smart contact lens systems for ocular drug delivery and therapy","volume":"196","author":"Kim","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2023.08.001_bib134","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/pharmaceutics12020155","article-title":"Novel sustained-release drug delivery system for dry eye therapy by rebamipide nanoparticles","volume":"12","author":"Nagai","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2023.08.001_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112255","article-title":"Formulation and development of tacrolimus-gellan gum nanoformulation for treatment of dry eye disease","volume":"211","author":"Modi","year":"2022","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jtos.2023.08.001_bib136","article-title":"Chitosan grafted methoxy poly (ethylene glycol)-poly (\u03b5-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac","volume":"5","author":"Shi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2023.08.001_bib137","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3109\/10717544.2016.1172368","article-title":"In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants","volume":"23","author":"Yavuz","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jtos.2023.08.001_bib138","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.2147\/IJN.S173198","article-title":"Gelatin\u2013epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief","volume":"13","author":"Huang","year":"2018","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jtos.2023.08.001_bib139","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/pharmaceutics13060905","article-title":"Dexamethasone-loaded nanostructured lipid carriers for the treatment of dry eye disease","volume":"13","author":"Kumari","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2023.08.001_bib140","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1080\/09205063.2021.1932359","article-title":"Formulation development, optimization, and in vitro assessment of thermoresponsive ophthalmic pluronic F127-chitosan in situ tacrolimus gel","volume":"32","author":"Modi","year":"2021","journal-title":"J Biomater Sci Polym Ed"},{"key":"10.1016\/j.jtos.2023.08.001_bib141","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1208\/s12249-017-0710-8","article-title":"PLGA nanoparticles as subconjunctival injection for management of glaucoma","volume":"18","author":"Salama","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jtos.2023.08.001_bib142","article-title":"Travoprost loaded microemulsion soaked contact lenses: improved drug uptake, release kinetics and physical properties","volume":"57","author":"Xu","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtos.2023.08.001_bib143","article-title":"Nano-in-Nano dendrimer gel particles for efficient topical delivery of antiglaucoma drugs into the eye","volume":"425","author":"Wang","year":"2021","journal-title":"Chem Eng J"},{"key":"10.1016\/j.jtos.2023.08.001_bib144","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1021\/acsbiomaterials.7b00319","article-title":"Fast dissolving dendrimer nanofiber mats as alternative to eye drops for more efficient antiglaucoma drug delivery","volume":"3","author":"Lancina","year":"2017","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.jtos.2023.08.001_bib145","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/polym11060929","article-title":"Osmoprotectants in hybrid liposome\/HPMC systems as potential glaucoma treatment","volume":"11","author":"G\u00f3mez-Ballesteros","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.jtos.2023.08.001_bib146","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1039\/C8BM00212F","article-title":"Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation","volume":"6","author":"Desai","year":"2018","journal-title":"Biomater Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib147","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.carbpol.2013.10.079","article-title":"In situ gelling dorzolamide loaded chitosan nanoparticles for the treatment of glaucoma","volume":"102","author":"Katiyar","year":"2014","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.jtos.2023.08.001_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202104657","article-title":"A rapid corneal healing microneedle for efficient ocular drug delivery","volume":"18","author":"Shi","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jtos.2023.08.001_bib149","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/08982104.2016.1224899","article-title":"Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy","volume":"27","author":"Fu","year":"2017","journal-title":"J Liposome Res"},{"key":"10.1016\/j.jtos.2023.08.001_bib150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijpharm.2019.05.031","article-title":"Evaluating the potential of drug eluting contact lenses for treatment of bacterial keratitis using an ex vivo corneal model","volume":"565","author":"Ubani-Ukoma","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2023.08.001_bib151","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.xphs.2021.12.016","article-title":"Pharmacokinetic and pharmacodynamic evaluation of gemifloxacin chitosan nanoparticles as an antibacterial ocular dosage form","volume":"111","author":"Hassan","year":"2022","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.jtos.2023.08.001_bib152","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ijbiomac.2018.05.113","article-title":"Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride","volume":"116","author":"Liu","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jtos.2023.08.001_bib153","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nano.2009.10.004","article-title":"Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery","volume":"6","author":"Gupta","year":"2010","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.jtos.2023.08.001_bib154","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.xphs.2021.04.020","article-title":"Novel chitosan-coated niosomal formulation for improved management of bacterial conjunctivitis: a highly permeable and efficient ocular nanocarrier for azithromycin","volume":"110","author":"Eid","year":"2021","journal-title":"J Pharmaceut Sci"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154201242300099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154201242300099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:50:42Z","timestamp":1761540642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154201242300099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":154,"alternative-id":["S154201242300099X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2023.08.001","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular nature of ocular surface barrier function, diseases that affect it, and its relevance for ocular drug delivery","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2023.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}